» Articles » PMID: 29548320

Total RNA Extraction from Tissues for MicroRNA and Target Gene Expression Analysis: Not All Kits Are Created Equal

Overview
Journal BMC Biotechnol
Publisher Biomed Central
Specialty Biotechnology
Date 2018 Mar 18
PMID 29548320
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: microRNAs (miRNAs) are short non-coding RNAs that fine-tune gene expression. The aberrant expression of miRNAs is associated with many diseases and they have both therapeutic and biomarker potential. However, our understanding of their usefulness is dependent on the tools we have to study them. Previous studies have identified the need to optimise and standardise RNA extraction methods in order to avoid biased results. Herein, we extracted RNA from murine lung, liver and brain tissues using five commercially available total RNA extraction methods. These included either: phenol: chloroform extraction followed by alcohol precipitation (TRIzol), phenol:chloroform followed by solid-phase extraction (column-based; miRVana and miRNeasy) and solid-phase separation with/without affinity resin (Norgen total and Isolate II). We then evaluated each extraction method for the quality and quantity of RNA recovered, and the expression of miRNAs and target genes.

Results: We identified differences between each of the RNA extraction methods in the quantity and quality of RNA samples, and in the analysis of miRNA and target gene expression. For the purposes of consistency in quantity, quality and high recovery of miRNAs from tissues, we identified that Phenol:chloroform phase separation combined with silica column-based solid extraction method was preferable (miRVana microRNA isolation). We also identified a method that is not appropriate for miRNA analysis from tissue samples (Bioline Isolate II). For target gene expression any of the kits could be used to analyse mRNA, but if interested in analysing mRNA and miRNA from the same RNA samples some methods should be avoided.

Conclusions: Different methods used to isolate miRNAs will yield different results and therefore a robust RNA isolation method is required for reproducibility. Researchers should optimise these methods for their specific application and keep in mind that "total RNA" extraction methods do not isolate all types of RNA equally.

Citing Articles

MicroRNAs in idiopathic childhood nephrotic syndrome.

Sinha A, Sra M, Ahmed A, Mallick S, Saini H, Devi K Clin Exp Nephrol. 2024; .

PMID: 39630311 DOI: 10.1007/s10157-024-02595-3.


A comprehensive study of genetic regulation and disease associations of plasma circulatory microRNAs using population-level data.

Mustafa R, Mens M, van Hilten A, Huang J, Roshchupkin G, Huan T Genome Biol. 2024; 25(1):276.

PMID: 39434104 PMC: 11492503. DOI: 10.1186/s13059-024-03420-6.


Analyzing the mutational landscape of prostate cancer susceptibility genes through next-generation sequencing (NGS).

Riaz F, Sultana S, Asad L, Mirjat D, Shazi M, Zia M Am J Transl Res. 2024; 16(9):4450-4465.

PMID: 39398597 PMC: 11470312. DOI: 10.62347/QRIF7244.


Optimizing total RNA extraction method for human and mice samples.

Zeng Y, Tang X, Chen J, Kang X, Bai D PeerJ. 2024; 12:e18072.

PMID: 39346072 PMC: 11439393. DOI: 10.7717/peerj.18072.


Oncogenic microRNA-1290 and Gene as Potential Biomarker for Colorectal Carcinoma.

Naseem R, Shahid S, Shahid W, Abbas G Technol Cancer Res Treat. 2024; 23:15330338241286283.

PMID: 39327992 PMC: 11439174. DOI: 10.1177/15330338241286283.


References
1.
Korpal M, Kang Y . The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol. 2009; 5(3):115-9. PMC: 3532896. DOI: 10.4161/rna.5.3.6558. View

2.
Eldh M, Lotvall J, Malmhall C, Ekstrom K . Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol. 2012; 50(4):278-86. DOI: 10.1016/j.molimm.2012.02.001. View

3.
Kredo-Russo S, Ness A, Mandelbaum A, Walker M, Hornstein E . Regulation of pancreatic microRNA-7 expression. Exp Diabetes Res. 2012; 2012:695214. PMC: 3362837. DOI: 10.1155/2012/695214. View

4.
Horsham J, Kalinowski F, Epis M, Ganda C, Brown R, Leedman P . Clinical Potential of microRNA-7 in Cancer. J Clin Med. 2015; 4(9):1668-87. PMC: 4600152. DOI: 10.3390/jcm4091668. View

5.
Choi J, Kang S, Lee Y, Hong S, Sanek N, Young W . MicroRNA profiling in the mouse hypothalamus reveals oxytocin-regulating microRNA. J Neurochem. 2013; 126(3):331-7. PMC: 3716862. DOI: 10.1111/jnc.12308. View